Total Visits

Views
Randomized phase II study of abiraterone acetate maintenance in combination with docetaxel after disease progression to abiraterone acetate in metastatic castration-resistant prostate cancer (mCRPC): ABIDO SOGUG trial9

Select a period of time:

Views

Views
May 20244
June 20240
July 20241
August 20240
September 20240
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Chicago2
Fort Worth2